{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:26:31Z","timestamp":1786119991837,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1097\/gme.0b013e31821e21f5","type":"journal-article","created":{"date-parts":[[2011,6,29]],"date-time":"2011-06-29T07:32:36Z","timestamp":1309332756000},"page":"1198-1204","source":"Crossref","is-referenced-by-count":65,"title":["Elevated serum visfatin\/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters"],"prefix":"10.1097","volume":"18","author":[{"given":"Maria","family":"Dalamaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Karmaniolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Papadavid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaos","family":"Pelekanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Sotiropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antigoni","family":"Lekka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210211","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1210\/er.2006-0019","article-title":"Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women.","volume":"28","author":"Rose","year":"2007","journal-title":"Endocr Rev"},{"key":"R2-10-20210211","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/gme.0b013e3181788d88","article-title":"Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer.","volume":"15","author":"Vogel","year":"2008","journal-title":"Menopause"},{"key":"R3-10-20210211","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1002\/ijc.21730","article-title":"Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort.","volume":"118","author":"Rinaldi","year":"2006","journal-title":"Int J Cancer"},{"key":"R4-10-20210211","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ijc.23303","article-title":"Early life events and conditions and breast cancer risk: from epidemiology to etiology.","volume":"122","author":"Trichopoulos","year":"2008","journal-title":"Int J Cancer"},{"key":"R5-10-20210211","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1470-2045(00)00254-0","article-title":"Epidemiology of breast cancer.","volume":"2","author":"Key","year":"2001","journal-title":"Lancet Oncol"},{"key":"R6-10-20210211","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archsurg.140.1.58","article-title":"Risk factors for estrogen receptor-positive breast cancer.","volume":"140","author":"Hwang","year":"2005","journal-title":"Arch Surg"},{"key":"R7-10-20210211","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1001\/jama.286.17.2143","article-title":"Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms.","volume":"286","author":"Singletary","year":"2001","journal-title":"JAMA"},{"key":"R8-10-20210211","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1467-789X.2004.00142.x","article-title":"Obesity, adipocytokines, and insulin resistance in breast cancer.","volume":"5","author":"Rose","year":"2004","journal-title":"Obesity Rev"},{"key":"R9-10-20210211","first-page":"42","article-title":"Fasting insulin and outcome in early-stage breast cancer: results from a prospective cohort study J Clin","volume":"20","author":"Goodwin","year":"2002","journal-title":"Oncol"},{"key":"R10-10-20210211","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1677\/erc.0.0060165","article-title":"Aromatase and breast cancer susceptibility.","volume":"6","author":"Pobst-Hensch","year":"1999","journal-title":"Endocr Relat Cancer"},{"key":"R11-10-20210211","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7326\/0003-4819-152-2-201001190-00008","article-title":"Narrative review: the role of leptin in human physiology: emerging clinical applications.","volume":"152","author":"Kelesidis","year":"2010","journal-title":"Ann Intern Med"},{"key":"R12-10-20210211","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3945\/ajcn.2009.28449C","article-title":"Adiponectin in insulin resistance: lessons from translational research.","volume":"91","author":"Ziemke","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"R13-10-20210211","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1210\/jc.2003-031804","article-title":"Adiponectin and breast cancer risk.","volume":"89","author":"Mantzoros","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-10-20210211","first-page":"1285","article-title":"Adverse effects of obesity on breast cancer prognosis, and the biologic actions of leptin.","volume":"21","author":"Rose","year":"2002","journal-title":"Int J Oncol"},{"key":"R15-10-20210211","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tem.2008.10.004","article-title":"Nampt: linking NAD biology, metabolism and cancer.","volume":"20","author":"Garten","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"R16-10-20210211","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.2174\/138161210791208947","article-title":"Pre-B cell colony enhancing factor\/Nampt\/visfatin in inflammation and obesity-related disorders.","volume":"16","author":"Moschen","year":"2010","journal-title":"Curr Pharm Des"},{"key":"R17-10-20210211","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2174\/138161209787185814","article-title":"Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases.","volume":"15","author":"Imai","year":"2009","journal-title":"Curr Pharm Des"},{"key":"R18-10-20210211","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00535-009-0063-5","article-title":"Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer.","volume":"44","author":"Nakajima","year":"2009","journal-title":"J Gastroenterol"},{"key":"R19-10-20210211","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1349-7006.2010.01518.x","article-title":"Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer.","volume":"101","author":"Nakajima","year":"2010","journal-title":"Cancer Sci"},{"key":"R20-10-20210211","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10059-010-0124-x","article-title":"Visfatin stimulates proliferation of MCF7 human breast cancer cells.","volume":"30","author":"Kim","year":"2010","journal-title":"Mol Cells"},{"key":"R21-10-20210211","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1080\/10428190600688552","article-title":"Clinical study on the serum carcinoembryonic antigen, CA 19-9, CA 50, and -fetoprotein levels in patients with myelodysplastic syndromes.","volume":"47","author":"Dalamaga","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"R22-10-20210211","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10552-008-9233-7","article-title":"Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study.","volume":"20","author":"Dalamaga","year":"2009","journal-title":"Cancer Causes Control"},{"key":"R23-10-20210211","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1055\/s-0029-1241870","article-title":"Obesity and cancer.","volume":"117","author":"Percik","year":"2009","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R24-10-20210211","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1365-2265.2007.02966.x","article-title":"Circulating visfatin level is correlated with inflammation, but not with insulin resistance.","volume":"67","author":"Oki","year":"2007","journal-title":"Clin Endocrinol"},{"key":"R25-10-20210211","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.metabol.2007.04.018","article-title":"The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women.","volume":"56","author":"Chen","year":"2007","journal-title":"Metabolism"},{"key":"R26-10-20210211","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","article-title":"Visfatin: a protein secreted by visceral fat that mimics the effects of insulin.","volume":"307","author":"Fukuhara","year":"2005","journal-title":"Science"},{"key":"R27-10-20210211","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1126\/science.318.5850.565b","article-title":"Retraction.","volume":"318","author":"Fukuhara","year":"2007","journal-title":"Science"},{"key":"R28-10-20210211","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0014-5793(99)01578-1","article-title":"A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization.","volume":"463","author":"Hufton","year":"1999","journal-title":"FEBS Lett"},{"key":"R29-10-20210211","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1016\/j.febslet.2006.06.052","article-title":"Hypoxic induction of human visfatin gene is directly mediated by hypoxia-inducible factor-1.","volume":"580","author":"Bae","year":"2006","journal-title":"FEBS Lett"},{"key":"R30-10-20210211","doi-asserted-by":"crossref","first-page":"7434","DOI":"10.1158\/1078-0432.CCR-04-0548","article-title":"Gene expression profile associated with response to doxorubicin-based therapy in breast cancer.","volume":"11","author":"Folgueira","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R31-10-20210211","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.peptides.2009.10.001","article-title":"A novel role for the adipokine visfatin\/pre-B cell colony-enhancing factor 1 in prostate carcinogenesis.","volume":"31","author":"Patel","year":"2010","journal-title":"Peptides"},{"key":"R32-10-20210211","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.peptides.2009.12.004","article-title":"Estrogens induce visfatin expression in 3T3-L1 cells.","volume":"31","author":"Zhou","year":"2010","journal-title":"Peptides"},{"key":"R33-10-20210211","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1210\/jc.2006-1975","article-title":"Plasma adiponectin concentrations and risk of incident breast cancer.","volume":"92","author":"Tworoger","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R34-10-20210211","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.bjc.6603051","article-title":"Adiponectin and cancer: a systematic review.","volume":"94","author":"Kelesidis","year":"2006","journal-title":"Br J Cancer"},{"key":"R35-10-20210211","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.ejca.2008.04.015","article-title":"Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system.","volume":"44","author":"Dalamaga","year":"2008","journal-title":"Eur J Cancer"},{"key":"R36-10-20210211","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000120995","article-title":"Circulating adiponectin and leptin in relation to myelodysplastic syndrome: a case-control study.","volume":"73","author":"Dalamaga","year":"2007","journal-title":"Oncology"},{"key":"R37-10-20210211","first-page":"1285","article-title":"Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin.","volume":"21","author":"Rose","year":"2002","journal-title":"Int J Oncol"},{"key":"R38-10-20210211","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1249\/MSS.0b013e318195bad5","article-title":"Decreased visfatin after exercise training correlates with improved glucose tolerance.","volume":"41","author":"Haus","year":"2009","journal-title":"Med Sci Sports Exerc"},{"key":"R39-10-20210211","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.bbrc.2008.01.019","article-title":"Anticancer agent CHS-828 inhibits cellular synthesis of NAD.","volume":"367","author":"Olesen","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"R40-10-20210211","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1753-4887.2006.tb00178.x","article-title":"Does a high folate intake increase the risk of breast cancer?","volume":"64","author":"Kim","year":"2006","journal-title":"Nutr Rev"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00042192-201111000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:31:17Z","timestamp":1786044677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042192-201111000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e31821e21f5","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}